Bor-Chyuan Su

8PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 24, 2026
Epinecidin-1 Induces Distinct Oncosis and Pyroptosis Responses in Osteosarcoma Cells and Enhances Methotrexate-associated Cytotoxicity.

|Jul 31, 2026
Assessing tumor heterogeneity and FLOT/FOLFOX-induced alterations in cancer stem cells and cancer immune checkpoint molecules using patient-derived tumor organoids.

|Jul 09, 2025
Hyperthermia-induced cytotoxicity and modulation of PD-L1 and MHC-I expression in human non-small cell lung cancer cell lines.

Yun-Chieh Tu, Wei-Chen Yeh, Yi-Wei Fang

|May 17, 2025
Chemotherapy elevates cell surface PD-L1 and MHC-I expression in apoptotic gastric cancer cells.

You-Syuan Lou, Xu-Chen Liu, Chih-Cheng Cheng

|Jul 19, 2024
Combination of Vismodegib and Paclitaxel Enhances Cytotoxicity via Bak-mediated Mitochondrial Damage in EGFR-Mutant Non-Small Cell Lung Cancer Cells.

Wei-Chen Yeh, Yun-Chieh Tu, Pei-Ling Hsu

|Apr 03, 2024
Repurposing the diuretic benzamil as an anti-osteosarcoma agent that acts by suppressing integrin/FAK/STAT3 signalling and compromising mitochondrial function.

Meng-Chieh Lin, Guan-Yu Chen, Hsin-Hsien Yu

Pageof 2

Frequent Collaborators

7 joint publications

Hsin-Hsien Yu

5 joint publications

Chih-Cheng Cheng

4 joint publications

Pei-Ling Hsu

4 joint publications

Chu-Wan Lee